OTC Markets OTCPK - Delayed Quote USD

Ludwig Enterprises, Inc. (LUDG)

0.0900

-0.0200

(-18.18%)

At close: April 16 at 3:01:06 PM EDT

Ludwig Enterprises Begins PCR Validation Test Process

Final step before the full launch of breast cancer screening program, Revealia™ SPARKS, NV / ACCESSWIRE / November 7, 2024 / Ludwig Enterprises, Inc. (OTC PINK:LUDG), a leading USA-based biotechnology company (the "Company"), has retained an independent ...

ACCESS Newswire 5 months ago

LUDG
-18.18%
Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)

SPARKS, NV / ACCESSWIRE / October 24, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a leading USA-based biotechnology company, has filed a provisional patent for its breakthrough cancer detection method titled "mRNAs Differentially Expressed in ...

ACCESS Newswire 5 months ago

LUDG
-18.18%
CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

This press release replaces the release issued today at 9:15am EDT. Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy. Revealia™: A Breakthrough in Cancer Detection ...

ACCESS Newswire 6 months ago

LUDG
-18.18%
Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy. Revealia™: A Breakthrough in Cancer Detection through Advanced AI and Machine Learning SPARKS, NV / ACCESSWIRE / September 24, ...

ACCESS Newswire 6 months ago

LUDG
-18.18%
Ludwig Announces Acquisition of Intellectual Property and Patent

SPARKS, NV / ACCESSWIRE / September 17, 2024 / Ludwig Enterprises, Inc., (OTC PINK:LUDG), a USA-based biotechnology company, is pleased to announce it has acquired all the intellectual property and patent of the mRNA Neuro Panel and Serotonin Assay, ...

ACCESS Newswire 6 months ago

LUDG
-18.18%
Nova Mentis Assigns Intellectual Property

Vancouver, British Columbia--(Newsfile Corp. - August 27, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") is pleased to announce it has entered into an intellectual property conveyance agreement (the "Agreement") with Ludwig Enterprises Inc. ("LUDG") and Dr. Marvin S. Hausman ("Hausman"), CEO of Ludwig, pursuant to which the Company shall assign to Ludwig all of its intellectual property and patent of the mRNA Neuro Panel ...

Newsfile 7 months ago

NMLSF

LUDG
-18.18%
Ludwig Announces Substantial Corporate Initiatives

Revealia™, the world’s most convenient cancer screening test, to launch in 2024 SPARKS, NV / ACCESSWIRE / August 14, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a USA-based biotechnology company, is pleased to announce its corporate ...

ACCESS Newswire 7 months ago

LUDG
-18.18%
Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer

SPARKS, NV / ACCESSWIRE / July 9, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a USA based biotechnology company is pleased to announce that the company has filed a provisional patent titled "mRNAs DIFFERENTIALLY EXPRESSED IN COLORECTAL CANCER, ...

ACCESS Newswire 9 months ago

LUDG
-18.18%

Performance Overview

Return	LUDG	S&P 500 (^GSPC)
YTD	-38.78%	-10.18%
1-Year	-70.00%	+5.19%
3-Year	+462.50%	+20.26%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Ludwig Enterprises, Inc. (LUDG)

Ludwig Enterprises Begins PCR Validation Test Process

Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)

CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

Ludwig Announces Acquisition of Intellectual Property and Patent

Nova Mentis Assigns Intellectual Property

Ludwig Announces Substantial Corporate Initiatives

Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer

Performance Overview